WeVote

Bill

Bill

HB 1636

Relating to designating certain substances as Schedule IV controlled substances under the Texas Controlled Substances Act.

89th Legislature (2025) Introduced by Pat Curry and 1 co-sponsor

HB 1636 adds unspecified substances to Texas's Schedule IV controlled substances list, criminalizing possession and distribution with potential jail time and fines.

Referred to Public Health
0
WeVote Research Nonpartisan
Bill Summary · HB 1636

Legislative bill overview

HB 1636 proposes to add specific substances to Schedule IV of the Texas Controlled Substances Act, making them regulated controlled substances with associated criminal penalties. The bill was filed in December 2024 and recently advanced to first reading in March 2025, currently under review by the Public Health Committee.

Why is this important

Schedule IV designation creates legal consequences for possession, distribution, and manufacture—including criminal charges, jail time, and fines. This directly affects public health policy, law enforcement priorities, and individuals who may possess these substances for medical, research, or personal reasons. The classification also influences how Texas aligns with federal drug policy and impacts healthcare providers' ability to prescribe certain medications.

Potential points of contention

  • Specificity unclear: The bill summary doesn't identify which substances are being scheduled, making it difficult to assess whether the designation is scientifically justified or overly broad
  • Medical and research implications: Schedule IV status may restrict legitimate medical use or research applications of these substances, potentially limiting treatment options
  • Criminal justice impact: Additional drug scheduling increases incarceration risk and criminal records, with documented disparate effects on certain communities; enforcement costs and prison populations may increase

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.